Medical Properties Trust — NYSE: MPW, also known as MPT — is one of the most painful positions for dividend investors over the past several years. From a peak above $20 to under $4. Dividend cut three times. Two major tenants in crisis. And yet one of the world’s largest hospital landlords still holds a dividend yield of 7.4%.
In this analysis I go through the full story: where the crash came from, what the Q4 2025 turnaround is worth in practical terms, and what Q1 2026 earnings must show for the investment thesis to hold.
My position, transparent: 229 shares at an average of €5.45 — current price €4.41. Book loss €237 minus €119 in received dividends = net loss €118 at time of recording. No sugarcoating.
1. What Is Medical Properties Trust and How Does It Work?
Medical Properties Trust is not a conventional real estate REIT with office buildings or logistics parks. It is a specialized hospital landlord operating through sale-leaseback transactions: MPW buys hospital buildings from operators and immediately leases them back long-term (typically 15-20 years). The operator gets fresh capital for investment or debt reduction; MPW gets a long-term tenant and predictable rent cash flows.
With over 400 hospitals in nine countries — USA, UK, Germany, Australia, Switzerland, Finland, Colombia, Portugal, Spain — MPW ranks among the largest hospital property owners in the world. The model sounds inherently defensive: healthcare is not cyclical, hospitals cannot simply relocate, and demographic trends create permanently high demand.
2. The Three Crash Bombs: How Medical Properties Trust Ended Up in Crisis
The stock decline of Medical Properties Trust is explained by three parallel shocks between 2023 and 2025:
Bomb 1: Steward Health Care Bankruptcy (2024)
Steward was MPW’s largest single tenant — roughly 20% of the entire rental portfolio. In 2024, Steward filed for Chapter 11 bankruptcy. MPW initially received no regular rent payments, was forced to take massive write-downs, and invested months in the restructuring process. Many of Steward’s 30+ hospitals were ultimately transferred to new operators or closed — a complex, lengthy process that tied up significant management capacity.
Bomb 2: Prospect Medical Distress (2024–2025)
Before the Steward crisis had fully resolved, Prospect Medical fell into financial difficulties. California hospitals in particular were unable to fully meet their rent obligations. MPW had to negotiate, take valuation adjustments, and ultimately re-lease the California portfolio to a new operator.
Bomb 3: Triple Dividend Cut
The combined cash flow shortfalls forced MPW into three dividend cuts in rapid succession: $0.29 → $0.15 → $0.09 per quarter = minus 70%. Every cut triggered a new wave of selling and put long-term dividend investors — who had held the REIT precisely for its stable distribution history — under severe pressure.
3. Q4 2025: The Turnaround Is Real
The first significant positive signal came with Q4 2025 results: Medical Properties Trust posted a net profit of +$17 million — the first profitable quarter after a prolonged loss period. Most of the Steward write-downs are behind it, and the Prospect exposure is being replaced by the California deal.
In parallel, the dividend was confirmed at $0.09 per quarter. That is the stabilizing base: 7.4% yield paid while waiting for normalization. In the REIT cycle, this is an interesting starting position — provided one can carry the risk profile.
4. Key Metrics: Where Does Medical Properties Trust Stand in 2026?
- Share Price (April 2026): ~$4.85 (USD) / ~€4.41
- Dividend: $0.09/quarter = $0.36 annualized
- Dividend Yield: ~7.4%
- Portfolio: 400+ hospitals across 9 countries
- NFFO Q4 2025: Positive — first turnaround after loss quarters
- California Deal: $45M/year, 15-year term (through 2039)
- Market Cap: ~$2.9B — trading well below historical book value
5. My Position and Decision Framework
229 shares at €5.45 average. Book loss €237. Dividends received €119. Net position: −€118. This is my biggest open wound in the portfolio — but I am holding deliberately:
- Turnaround is real: Q4 2025 showed positive NFFO for the first time again.
- California deal: Secures $45M/year for 15 years — hard rent visibility through 2039.
- Dividend paid while waiting: 7.4% yield compensates for the holding period.
- Rate pivot option: REITs structurally benefit from falling rates. At a Fed pivot from 2027, MPW could respond disproportionately.
6. Q1 2026 Earnings Check: What Must Medical Properties Trust Deliver?
Q1 2026 results were published on April 30, 2026 before market open. My clear decision framework:
- MUST: Positive NFFO — negative NFFO is an immediate sell signal.
- MUST: Dividend confirmed at $0.09 for Q2 2026 — any further cut forces position reduction.
- SHOULD: California deal payments on track ($45M/year progressing as planned).
- BONUS: New tenant pipeline for remaining Steward properties — further occupancy recovery.
- WARNING: Guidance cut or new material tenant problems → immediate reassessment required.
The REIT series continues with REIT #02 STAG Industrial. In parallel, the Pharma series runs with Novo Nordisk as #01. Medical Properties Trust stays on my active watchlist with clearly defined trigger points in both directions.